|
1
|
Yao Y, Shen D, Chen R, Ying C, Wang C, Guo
J and Zhang G: Galectin-3 predicts left ventricular remodeling of
hypertension. J Clin Hypertens (Greenwich). 18:506–511. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou Y, Fang H, Lin S, Shen S, Tao L, Xiao
J and Li X: Qiliqiangxin protects against cardiac
ischemia-reperfusion injury via activation of the mTOR pathway.
Cell Physiol Biochem. 37:454–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Decker JA: Arrhythmias in paediatric
valvar disease. Cardiol Young. 24:1064–1070. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu H, Tian A, Wu J, Yang C, Xing R, Jia P,
Yang L, Zhang Y, Zheng X and Li Z: Danshensu inhibits β-adrenergic
receptors-mediated cardiac fibrosis by ROS/p38 MAPK axis. Biol
Pharm Bull. 37:961–967. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Löfsjögård J, Persson H, Díez J, López B,
González A, Edner M, Mejhert M and Kahan T: Atrial fibrillation and
biomarkers of myocardial fibrosis in heart failure. Scand
Cardiovasc J. 48:299–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sirish P, Li N, Liu JY, Lee KS, Hwang SH,
Qiu H, Zhao C, Ma SM, López JE, Hammock BD and Chiamvimonvat N:
Unique mechanistic insights into the beneficial effects of soluble
epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.
Proc Natl Acad Sci USA. 110:pp. 5618–5623. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang L, Zou XJ, Gao X, Chen H, Luo JL,
Wang ZH, Liang QS and Yang GT: Sodium tanshinone IIA sulfonate
attenuates angiotensin II-induced collagen type I expression in
cardiac fibroblasts in vitro. Exp Mol Med. 41:508–516. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Freed DH, Chilton L, Li Y, Dangerfield AL,
Raizman JE, Rattan SG, Visen N, Hryshko LV and Dixon IM: Role of
myosin light chain kinase in cardiotrophin-1-induced cardiac
myofibroblast cell migration. Am J Physiol Heart Circ Physiol.
301:H514–H522. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freed DH, Borowiec AM, Angelovska T and
Dixon IM: Induction of protein synthesis in cardiac fibroblasts by
cardiotrophin-1: Integration of multiple signaling pathways.
Cardiovasc Res. 60:365–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
López B, González A, Querejeta R, Larman
M, Rábago G and Díez J: Association of cardiotrophin-1 with
myocardial fibrosis in hypertensive patients with heart failure.
Hypertension. 63:483–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ateghang B, Wartenberg M, Gassmann M and
Sauer H: Regulation of cardiotrophin-1 expression in mouse
embryonic stem cells by HIF-1alpha and intracellular reactive
oxygen species. J Cell Sci. 119:1043–1052. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai H, Jia G, Liu X, Liu Z and Wang H:
Astragalus polysaccharide inhibits isoprenaline-induced cardiac
hypertrophy via suppressing Ca2+-mediated
calcineurin/NFATc3 and CaMKII signaling cascades. Environ Toxicol
Pharmacol. 38:263–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Wang HX, Zhang YJ, Yang YH, Lu ML,
Zhang J, Li ST, Zhang SP and Li G: Astragaloside IV attenuates
inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway
in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol.
Oct 25–2013.(Epub ahead of print). View Article : Google Scholar
|
|
14
|
Jiang X, Cao X, Huang Y, Chen J, Yao X,
Zhao M, Liu Y, Meng J, Li P, Li Z, et al: Effects of treatment with
Astragalus membranaceus on function of rat leydig cells. BMC
Complement Altern Med. 15:2612015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mei M, Tang F, Lu M, He X, Wang H, Hou X,
Hu J, Xu C and Han R: Astragaloside IV attenuates apoptosis of
hypertrophic cardiomyocyte through inhibiting oxidative stress and
calpain-1 activation. Environ Toxicol Pharmacol. 40:764–773. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao P, Wang Y, Zeng S, Lu J, Jiang TM and
Li YM: Protective effect of astragaloside IV on
lipopolysaccharide-induced cardiac dysfunction via downregulation
of inflammatory signaling in mice. Immunopharmacol Immunotoxicol.
37:428–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen P, Xie Y, Shen E, Li GG, Yu Y, Zhang
CB, Yang Y, Zou Y, Ge J, Chen R and Chen H: Astragaloside IV
attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in
coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol.
658:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai H, Jia G, Lu M, Liang C, Wang Y and
Wang H: Astragaloside IV inhibits isoprenaline-induced cardiac
fibrosis by targeting the reactive oxygen species/mitogen-activated
protein kinase signaling axis. Mol Med Rep. 15:1765–1770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai H, Song D, Xu J, Li B, Hertz L and
Peng L: Ammonia-induced Na,K-ATPase/ouabain-mediated EGF receptor
transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation
cause astrocyte swelling. Neurochem Int. 63:610–625. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu M, Zheng Y, Sun HX and Yu DJ:
Inhibitory effects of enalaprilat on rat cardiac fibroblast
proliferation via ROS/P38MAPK/TGF-β1 signaling pathway. Molecules.
17:2738–2751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porter KE and Turner NA: Cardiac
fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther.
123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ye Y, Lv X, Wang MH, Zhu J, Chen SQ, Jiang
CY and Fu GS: Alendronate prevents angiotensin II-induced collagen
I production through geranylgeranylation-dependent RhoA/Rho kinase
activation in cardiac fibroblasts. J Pharmacol Sci. 129:205–209.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu LM and Xu Y: Epigenetic regulation in
cardiac fibrosis. World J Cardiol. 7:784–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Putten S, Shafieyan Y and Hinz B:
Mechanical control of cardiac myofibroblasts. J Mol Cell Cardiol.
93:133–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chimura M, Kiuchi K, Okajima K, Shimane A,
Sawada T, Onishi T, Yamada S, Taniguchi Y, Yasaka Y and Kawai H:
Distribution of ventricular fibrosis associated with life
threatening ventricular tachyarrhythmias in patients with
nonishcemic dilated cardiomyopathy. J Cardiovasc Electrophysiol.
Jul 29–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu H, Li GN, Xie J, Li R, Chen QH, Chen
JZ, Wei ZH, Kang LN and Xu B: Resveratrol ameliorates myocardial
fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in
STZ-induced diabetic mice. BMC Cardiovasc Disord. 16:52016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghule AE, Kandhare AD, Jadhav SS, Zanwar
AA and Bodhankar SL: Omega-3-fatty acid adds to the protective
effect of flax lignan concentrate in pressure overload-induced
myocardial hypertrophy in rats via modulation of oxidative stress
and apoptosis. Int Immunopharmacol. 28:751–763. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
An LP, An SK, Wei XH, Fu SY and Wu HA:
Atorvastatin improves cardiac function of rats with chronic cardiac
failure via inhibiting
Rac1/P47phox/P67phox-mediated ROS release.
Eur Rev Med Pharmacol Sci. 19:3940–3946. 2015.PubMed/NCBI
|
|
29
|
Bartz RR, Suliman HB and Piantadosi CA:
Redox mechanisms of cardiomyocyte mitochondrial protection. Front
Physiol. 6:2912015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schunke KJ, Coyle L, Merrill GF and
Denhardt DT: Acetaminophen attenuates doxorubicin-induced cardiac
fibrosis via osteopontin and GATA4 regulation: Reduction of oxidant
levels. J Cell Physiol. 228:2006–2014. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen O, Ye Z, Cao Z, Manaenko A, Ning K,
Zhai X, Zhang R, Zhang T, Chen X, Liu W and Sun X: Methane
attenuates myocardial ischemia injury in rats through
anti-oxidative, anti-apoptotic and anti-inflammatory actions. Free
Radic Biol Med. 90:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mathur P, Ding Z, Saldeen T and Mehta JL:
Tocopherols in the prevention and treatment of atherosclerosis and
related cardiovascular disease. Clin Cardiol. 38:570–576. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gu DM, Lu PH, Zhang K, Wang X, Sun M, Chen
GQ and Wang Q: EGFR mediates astragaloside IV-induced Nrf2
activation to protect cortical neurons against in vitro
ischemia/reperfusion damages. Biochem Biophys Res Commun.
457:391–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu JY, Han J, Chu ZG, Song HP, Zhang DX,
Zhang Q and Huang YS: Astragaloside IV attenuates hypoxia-induced
cardiomyocyte damage in rats by upregulating superoxide dismutase-1
levels. Clin Exp Pharmacol Physiol. 36:351–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng ZZ, Fu X Tian, Liang J and Guo Z
Bing: CT-1 induces angiogenesis by regulating the ADMA/DDAH
pathway. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
159:540–546. 2015.PubMed/NCBI
|
|
36
|
Pennica D, King KL, Shaw KJ, Luis E,
Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR, et
al: Expression cloning of cardiotrophin 1, a cytokine that induces
cardiac myocyte hypertrophy. Proc Natl Acad Sci USA. 92:pp.
1142–1146. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
López-Andrés N, Martin-Fernandez B,
Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V and Díez
J: A role for cardiotrophin-1 in myocardial remodeling induced by
aldosterone. Am J Physiol Heart Circ Physiol. 301:H2372–H2382.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsuruda T, Jougasaki M, Boerrigter G,
Huntley BK, Chen HH, D'Assoro AB, Lee SC, Larsen AM, Cataliotti A
and Burnett JC Jr: Cardiotrophin-1 stimulation of cardiac
fibroblast growth: Roles for glycoprotein 130/leukemia inhibitory
factor receptor and the endothelin type A receptor. Circ Res.
90:128–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yin F, Li P, Zheng M, Chen L, Xu Q, Chen
K, Wang YY, Zhang YY and Han C: Interleukin-6 family of cytokines
mediates isoproterenol-induced delayed STAT3 activation in mouse
heart. J Biol Chem. 278:21070–21075. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang S, Tang F, Yang Y, Lu M, Luan A,
Zhang J, Yang J and Wang H: Astragaloside IV protects against
isoproterenol-induced cardiac hypertrophy by regulating
NF-κB/PGC-1α signaling mediated energy biosynthesis. PLoS One.
10:e01187592015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Giam B, Chu PY, Kuruppu S, Smith AI,
Horlock D, Kiriazis H, Du XJ, Kaye DM and Rajapakse NW:
N-acetylcysteine attenuates the development of cardiac fibrosis and
remodeling in a mouse model of heart failure. Physiol Rep.
4:e127572016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Faramoushi M, Sasan R Amir, Sarraf V Sari
and Karimi P: Cardiac fibrosis and down regulation of GLUT4 in
experimental diabetic cardiomyopathy are ameliorated by chronic
exposures to intermittent altitude. J Cardiovasc Thorac Res.
8:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Wang H, Cui L, Zhang Y, Liu Y,
Chu X, Liu Z, Zhang J and Chu L: Continuing treatment with Salvia
miltiorrhiza injection attenuates myocardial fibrosis in chronic
iron-overloaded mice. PLoS One. 10:e01240612015. View Article : Google Scholar : PubMed/NCBI
|
